Vor Biopharma Inc.(VOR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

VOR Vor Biopharma Inc.

Not Yet Opened 05-21 16:00:00 EDT

15.04

-0.51

-3.28%

盘后14.90

-0.14-0.93%

19:43 EDT

High15.25	Low14.75	Vol1.04M
Open15.23	D1 Closing15.55	Amplitude3.22%
Mkt Cap814.95M	Tradable Cap657.40M	Total Shares54.19M
T/O15.59M	T/O Rate2.38%	Tradable Shares43.71M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"VOR","market":"US","secType":"STK","nameCN":"Vor Biopharma Inc.","latestPrice":15.04,"timestamp":1779393600000,"preClose":15.55,"halted":0,"volume":1039410,"hourTrading":{"tag":"盘后","latestPrice":14.9,"preClose":15.04,"latestTime":"19:43 EDT","volume":9390,"amount":141225.0764,"timestamp":1779407007183,"change":-0.14,"changeRate":-0.009309,"amplitude":0.029255},"delay":0,"changeRate":-0.03279742765273322,"floatShares":43710400,"shares":54185600,"eps":-46.32986,"marketStatus":"Not Yet Opened","change":-0.51,"latestTime":"05-21 16:00:00 EDT","open":15.23,"high":15.25,"low":14.75,"amount":15594139.34316,"amplitude":0.032154,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-46.32986,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1779436800000},"marketStatusCode":0,"adr":0,"listingDate":1612501200000,"exchange":"NASDAQ","adjPreClose":15.55,"preHourTrading":{"tag":"盘前","latestPrice":15.26,"preClose":15.55,"latestTime":"09:29 EDT","volume":2093,"amount":32114.439448,"timestamp":1779370199999,"change":-0.29,"changeRate":-0.01865,"amplitude":0.010341},"postHourTrading":{"tag":"盘后","latestPrice":14.9,"preClose":15.04,"latestTime":"19:43 EDT","volume":9390,"amount":141225.0764,"timestamp":1779407007183,"change":-0.14,"changeRate":-0.009309,"amplitude":0.029255},"volumeRatio":1.12579,"impliedVol":1.3167,"impliedVolPercentile":0.3373},"requestUrl":"/m/hq/s/VOR","defaultTab":"news","newsList":[{"id":"2636530003","title":"Vor Biopharma Price Target Maintained With a $31.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2636530003","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636530003?lang=en_us&edition=fundamental","pubTime":"2026-05-19 02:00","pubTimestamp":1779127200,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/VOR/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 18, 2026 14:00 ET (18:00 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VOR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635742886","title":"Vor Bio price target raised to $18 from $15 at Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2635742886","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635742886?lang=en_us&edition=fundamental","pubTime":"2026-05-15 01:08","pubTimestamp":1778778490,"startTime":"0","endTime":"0","summary":"Wedbush analyst Martin Fan raised the firm’s price target on Vor Bio (VOR) to $18 from $15 and keeps a Neutral rating on the shares. The firm notes...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vor-bio-price-target-raised-to-18-from-15-at-wedbush-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vor-bio-price-target-raised-to-18-from-15-at-wedbush-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VOR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635484527","title":"Vor Biopharma Is Maintained at Neutral by Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2635484527","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635484527?lang=en_us&edition=fundamental","pubTime":"2026-05-14 21:30","pubTimestamp":1778765400,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/VOR/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 14, 2026 09:30 ET (13:30 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VOR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635169047","title":"Wedbush Adjusts Price Target on Vor Biopharma to $18 From $15, Maintains Neutral Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2635169047","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635169047?lang=en_us&edition=fundamental","pubTime":"2026-05-14 18:45","pubTimestamp":1778755556,"startTime":"0","endTime":"0","summary":"Vor Biopharma (VOR) has an average rating of buy and mean price target of $37.88, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","VOR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635715505","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Staar Surgical (STAA), Halozyme (HALO) and Vor Biopharma (VOR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2635715505","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635715505?lang=en_us&edition=fundamental","pubTime":"2026-05-14 18:20","pubTimestamp":1778754044,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Staar Surgical (STAA), Halozyme (HALO) and Vor Biopharma (VOR). S...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-staar-surgical-staa-halozyme-halo-and-vor-biopharma-vor-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-staar-surgical-staa-halozyme-halo-and-vor-biopharma-vor-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","VOR","HALO","XLV","BK4548","BK4585","BK4198","LU0029874061.USD","HCSG","BK4588","LU0128526141.USD","LABU","BK4581","STAA","BK4139","LU0053671581.USD","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635787637","title":"Vor Biopharma Q1 Adj. EPS $(0.73) Beats $(0.78) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2635787637","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635787637?lang=en_us&edition=fundamental","pubTime":"2026-05-13 20:57","pubTimestamp":1778677037,"startTime":"0","endTime":"0","summary":"Vor Biopharma (NASDAQ:VOR) reported quarterly losses of $(0.73) per share which beat the analyst consensus estimate of $(0.78) by 6.41 percent. This is a 85.96 percent increase over losses of $(5.20) per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52520854/vor-biopharma-q1-adj-eps-0-73-beats-0-78-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VOR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635878717","title":"Earnings Flash (VOR) Vor Biopharma Posts Q1 Net Loss $5.11 a Share, vs. FactSet Est of $0.78 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2635878717","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635878717?lang=en_us&edition=fundamental","pubTime":"2026-05-13 20:51","pubTimestamp":1778676674,"startTime":"0","endTime":"0","summary":"Earnings Flash (VOR) Vor Biopharma Posts Q1 Net Loss $5.11 a Share, vs. FactSet Est of $0.78 Loss","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["VOR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635782178","title":"Vor Biopharma Q1 net loss widens","url":"https://stock-news.laohu8.com/highlight/detail?id=2635782178","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635782178?lang=en_us&edition=fundamental","pubTime":"2026-05-13 20:38","pubTimestamp":1778675924,"startTime":"0","endTime":"0","summary":"Vor Biopharma Q1 net loss widensOverviewU.S. biotech firm's Q1 net loss widenedR&D expenses fell yr/yr, mainly due to reduced spend on previous programs and lower headcountCompany ended Q1 with $491.5","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nL1N41Q0LQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VOR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635782596","title":"Vor Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2635782596","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635782596?lang=en_us&edition=fundamental","pubTime":"2026-05-13 20:30","pubTimestamp":1778675401,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nTUA6RPQG1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","VOR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635825607","title":"Vor Biopharma Q1 Net Income USD -219.6 Million VS. Ibes Estimate USD -32.8 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635825607","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635825607?lang=en_us&edition=fundamental","pubTime":"2026-05-13 20:30","pubTimestamp":1778675401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nPLX5E0FA0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VOR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634828145","title":"Hisense Mulakan Kempen FIFA World Cup 2026™, Dekatkan Peminat Dengan \"Menginovasi Kehidupan Lebih Cerah\"","url":"https://stock-news.laohu8.com/highlight/detail?id=2634828145","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634828145?lang=en_us&edition=fundamental","pubTime":"2026-05-11 20:44","pubTimestamp":1778503440,"startTime":"0","endTime":"0","summary":"QINGDAO, China, 11 Mei 2026 /PRNewswire/ -- Hisense, jenama terkemuka dalam elektronik pengguna dan peralatan rumah global, hari ini melancarkan iklan televisyen  terbaharunya sempena menyambut FIFA World Cup 2026 yang akan datang, sekali gus memulakan kempen baharu yang menyoroti kuasa emosi sukan bola sepak sambil merealisasikan visinya, Menginovasi Kehidupan Lebih Cerah.Bermula daripada padang bola peringkat akar umbi hinggalah ruang tamu yang dipenuhi harapan, TVC tersebut memaparkan detik kegembiraan, ketabahan dan perpaduan—memperlihatkan bagaimana bola sepak mewujudkan ikatan emosi yang menjangkau usia, budaya dan geografi.Dengan memperluas naratif daripada pertumbuhan individu kepada pengalaman kolektif, Hisense meletakkan kedudukannya bukan sekadar penaja—tetapi pendaya detik-detik bermakna. Teknologi RGB MiniLED miliknya dapat menjayakan tujuan ini melalui \"Warna Semula Jadi dan Sebenar\" bagi memberikan gamut warna ultra tinggi serta reproduksi tepat supaya setiap detik teras","market":"sg","thumbnail":"https://mma.prnewswire.com/media/2976322/Hisense_Kicks_Off_FIFA_World_Cup_2026_TM_Campaign.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2976322/Hisense_Kicks_Off_FIFA_World_Cup_2026_TM_Campaign.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/hisense-mulakan-kempen-fifa-world-cup-2026-dekatkan-peminat-dengan-menginovasi-kehidupan-lebih-cerah-302768199.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VOR","BK4139","TVC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634840893","title":"Hisense เปิดตัวแคมเปญ FIFA World Cup 2026™ พาแฟนบอลใกล้ชิดเกมการแข่งขันมากขึ้นผ่านแนวคิด \"Innovating a Brighter Life\"","url":"https://stock-news.laohu8.com/highlight/detail?id=2634840893","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634840893?lang=en_us&edition=fundamental","pubTime":"2026-05-11 14:39","pubTimestamp":1778481540,"startTime":"0","endTime":"0","summary":", , 11  2569 /PRNewswire/ -- Hisense   FIFA World Cup 2026   \"Innovating a Brighter Life\". si=cUlpwsu7wbYlPYn8 HisenseHisense  2512   160     IT   Omdia  Hisense  1  100  2566–2568  RGB MiniLED  RGB MiniLED   FIFA World Cup 2026 Hisense  SOURCE Hisense","market":"fut","thumbnail":"https://mma.prnewswire.com/media/2976323/Hisense_Kicks_Off_FIFA_World_Cup_2026_TM_Campaign.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2976323/Hisense_Kicks_Off_FIFA_World_Cup_2026_TM_Campaign.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/hisense--fifa-world-cup-2026--innovating-a-brighter-life-302767997.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VOR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634546534","title":"Vor Biopharma Advances Phase 3 Telitacicept Trial in Myasthenia Gravis, Keeping Investor Focus High","url":"https://stock-news.laohu8.com/highlight/detail?id=2634546534","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634546534?lang=en_us&edition=fundamental","pubTime":"2026-05-09 00:33","pubTimestamp":1778258009,"startTime":"0","endTime":"0","summary":"Vor Biopharma, Inc. ($VOR) announced an update on their ongoing clinical study. Vor Biopharma, Inc. is running a Phase 3 trial called UPSTREAM MG t...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vor-biopharma-advances-phase-3-telitacicept-trial-in-myasthenia-gravis-keeping-investor-focus-high?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vor-biopharma-advances-phase-3-telitacicept-trial-in-myasthenia-gravis-keeping-investor-focus-high?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VOR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633966241","title":"Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2633966241","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633966241?lang=en_us&edition=fundamental","pubTime":"2026-05-05 04:30","pubTimestamp":1777926601,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nTUAB37KBW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VOR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630231094","title":"Vor Bio files to sell 5.34M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2630231094","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630231094?lang=en_us&edition=fundamental","pubTime":"2026-04-28 04:37","pubTimestamp":1777322247,"startTime":"0","endTime":"0","summary":"16:13 EDT Vor Bio (VOR) files to sell 5.34M shares of common stock for holders Published first on TheFly – the ultimate source for real-time, marke...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vor-bio-files-to-sell-5-34m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vor-bio-files-to-sell-5-34m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","VOR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630317588","title":"Vor Biopharma Files for Resale of up to 5.3 Mln Shares of Common Stock by Selling Stockholders - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2630317588","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630317588?lang=en_us&edition=fundamental","pubTime":"2026-04-28 04:13","pubTimestamp":1777320790,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nFWN41A0M2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VOR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630715803","title":"Clene, Lovesac, HDFC Bank, State Street, Vor Shock","url":"https://stock-news.laohu8.com/highlight/detail?id=2630715803","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630715803?lang=en_us&edition=fundamental","pubTime":"2026-04-25 21:01","pubTimestamp":1777122079,"startTime":"0","endTime":"0","summary":"Insiders have been trading these 5 stocks: (($CLNN)), (($LOVE)), (($HDB)), (($STT)) and (($VOR)). Here is a breakdown of their recent trades and th...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/clene-lovesac-hdfc-bank-state-street-vor-shock?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/clene-lovesac-hdfc-bank-state-street-vor-shock?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1805238398.USD","SG9999014021.USD","LU0528227936.USD","HDB","LU2008162690.USD","SG9999014039.USD","LU0918141887.USD","LU0390134368.USD","IE0034235188.USD","LU2177674079.SGD","LU2663582299.SGD","LU1282648689.USD","LU0061475181.USD","LU0536402901.SGD","BK4523","IE0001KFT4U8.USD","LU1791710582.SGD","LU2226246903.HKD","LU0456842615.SGD","LU1894683348.USD","LU0307460401.USD","LU0348814723.USD","LU0918141705.HKD","VOR","IE00B3QW5Z07.USD","LU1854104046.USD","BK4535","LU1508157978.USD","LU1883839398.USD","LU2279701549.SGD","LU0197773160.USD","LU1894683264.USD","IE00B0JY6M65.USD","IE00B7N09G41.SGD","BK4588","LU0630378692.HKD","LU0797268264.HKD","LU0868486357.SGD","LU0630378429.USD","LU0287143357.SGD","LU0348816934.USD","LU0541502299.USD","LU2265009873.SGD","BK4139","IE00BYTNYM70.SGD","LU1105468828.SGD","LU1854103824.USD","STT","LU0431992006.USD","SG9999014005.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630487958","title":"Major Vor Biopharma Insider Makes a Multi-Million Dollar Move","url":"https://stock-news.laohu8.com/highlight/detail?id=2630487958","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630487958?lang=en_us&edition=fundamental","pubTime":"2026-04-25 10:01","pubTimestamp":1777082473,"startTime":"0","endTime":"0","summary":"New insider activity at Vor Biopharma ( ($VOR) ) has taken place on April 24, 2026. Director RA Capital Management, LLC has unloaded 165,150 shares...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/major-vor-biopharma-insider-makes-a-multi-million-dollar-move-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/major-vor-biopharma-insider-makes-a-multi-million-dollar-move-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VOR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630236878","title":"RA Capital Management disposes 165,150 Vor Biopharma shares worth $2.6 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2630236878","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630236878?lang=en_us&edition=fundamental","pubTime":"2026-04-25 06:13","pubTimestamp":1777068811,"startTime":"0","endTime":"0","summary":"RA Capital Management sold 165,150 shares of Vor Biopharma common stock on April 22, 2026 at a weighted average price of $15.77.RA Capital Healthcare Fund held 2,402,095 shares following transaction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vor Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 24, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260424:nNDL5qNGBm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"RA Capital Management disposes 165,150 Vor Biopharma shares worth $2.6 million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VOR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629060229","title":"Major Insider Move Rocks Vor Biopharma as Director Unloads Massive Stake","url":"https://stock-news.laohu8.com/highlight/detail?id=2629060229","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629060229?lang=en_us&edition=fundamental","pubTime":"2026-04-22 10:01","pubTimestamp":1776823268,"startTime":"0","endTime":"0","summary":"New insider activity at Vor Biopharma ( ($VOR) ) has taken place on April 21, 2026. Director Ra Capital Management, LLC has executed a major move i...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/major-insider-move-rocks-vor-biopharma-as-director-unloads-massive-stake-insider-trading-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/major-insider-move-rocks-vor-biopharma-as-director-unloads-massive-stake-insider-trading-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","VOR"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.vorbio.com","stockEarnings":[{"period":"1week","weight":-0.002},{"period":"1month","weight":-0.0086},{"period":"3month","weight":0.11},{"period":"6month","weight":1.0188},{"period":"1year","weight":3.116},{"period":"ytd","weight":0.1498}],"compareEarnings":[{"period":"1week","weight":-0.0073},{"period":"1month","weight":0.0549},{"period":"3month","weight":0.0773},{"period":"6month","weight":0.127},{"period":"1year","weight":0.2743},{"period":"ytd","weight":0.0892}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Vor Biopharma Inc., a clinical-stage company, engages in the development of engineered hematopoietic stem cell (eHSC) therapies for cancer patients. The company is developing lead product, tremtelectogene empogeditemcel (trem-cel), formerly VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. It also offers Mylotarg, a CD33-directed antibody drug conjugate (ADC) therapy for patients with leukemia; VCAR33, a CAR-T therapy designed to target CD33, a clinically validated target for AML, currently under preclinical and Phase 1/2 clinical studies; trem-cel + VCAR33 treatment system, currently under preclinical studies for the treatment of AML; and CD33-CLL1 treatment system, made with CD33-CLL1 multiplex-engineered eHSC and CD33-CLL1 multi-specific CAR-T, currently under preclinical studies for the treatment of AML. Vor Biopharma Inc. has a collaboration agreement with Akron BioProducts to develop and manufacture cGMP nucleases. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.04043},{"month":2,"riseRate":0.6,"avgChangeRate":0.020325},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.093017},{"month":4,"riseRate":0,"avgChangeRate":-0.182481},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.221924},{"month":6,"riseRate":0.4,"avgChangeRate":1.31333},{"month":7,"riseRate":0.2,"avgChangeRate":-0.043439},{"month":8,"riseRate":0.4,"avgChangeRate":0.001368},{"month":9,"riseRate":0.4,"avgChangeRate":-0.0543},{"month":10,"riseRate":0.6,"avgChangeRate":-0.046096},{"month":11,"riseRate":0.2,"avgChangeRate":-0.192554},{"month":12,"riseRate":1,"avgChangeRate":0.3146}],"exchange":"NASDAQ","name":"Vor Biopharma Inc.","nameEN":"Vor Biopharma Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Vor Biopharma Inc.(VOR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Vor Biopharma Inc.(VOR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Vor Biopharma Inc.,VOR,Vor Biopharma Inc.股票,Vor Biopharma Inc.股票老虎,Vor Biopharma Inc.股票老虎国际,Vor Biopharma Inc.行情,Vor Biopharma Inc.股票行情,Vor Biopharma Inc.股价,Vor Biopharma Inc.股市,Vor Biopharma Inc.股票价格,Vor Biopharma Inc.股票交易,Vor Biopharma Inc.股票购买,Vor Biopharma Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Vor Biopharma Inc.(VOR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Vor Biopharma Inc.(VOR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}